The OR calculation has shown that deregulated concentration of plasma and amniotic fluid asprosin, A1AT, and amniotic fluid IMA during the second trimester increased the risk of Down syndrome among pregnant women (p < 0.05). The gene discussed is FBN1; the disease is Down syndrome.